Alzheimer’s Study with Promising Results

The University of Colorado School of Medicine and University of South Florida are conducting a joint research effort to test the effectiveness of the drug leukine on Alzheimer’s patients.

The study sample is small with only 32 participants, 60 percent of which receive a placebo.  However, results indicate a rapid, positive response to the drug.  When tested after 18 days, the leukine patients showed a measurable improvement in cognitive testing and anecdotal improvement in their ability to take care of themselves as observed by caregivers.

The center at CU conducting the research is the Rocky Mountain Alzheimer’s Disease Center.  A subsequent study is being planned.  It is estimated that 5.5 million people suffer from this disease in the U.S. alone.

Read more at UCHealth News.

Register for the Summer State-of-the-State

Join us for a conversation with Aetna CEO Mark Bertolini.  REGISTER HERE.

Thank You For Your Loyalty.

HCCA, publishers of the Colorado Managed Care Newsletter, began reporting on the financing of healthcare in Colorado in December of 1983. As we begin our 34th year, we are grateful for the opportunity to be one of your sources of information in this ever-changing, healthcare market.